CoChat

Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial

McElroy, Susan L., Martens, Brian E., Mori, Nicole, Blom, Thomas J., Casuto, Leah S., Hawkins, John M., Keck, Paul E. · 2015 · International Clinical Psychopharmacology
Cited by 43

The DOI matches its Crossref record.

Abstract

This study evaluated the efficacy and tolerability of lisdexamfetamine (LDX) in the treatment of bipolar depression. Twenty-five outpatients with bipolar I or II disorder and syndromal depression despite at least 4 weeks of stable mood stabilizer and/or antipsychotic therapy were randomized to receive LDX (N=11) or placebo (N=14) in an 8-week, prospective, parallel-group, double-blind study. In the primary longitudinal analysis, LDX and placebo produced similar rates of improvement in depressive symptoms as assessed by the Montgomery-Asberg Depression Scale. However, LDX was associated with a statistically significantly greater rate of improvement in self-reported depressive symptoms and daytime sleepiness, and with greater reductions in fasting levels of low-density lipoprotein and total cholesterol. In the secondary baseline-to-endpoint analysis, LDX was associated with statistically significant improvements in self-reported measures of depression, daytime sleepiness, fatigue, and binge eating, as well as with improvements in fasting levels of triglycerides and low-density lipoprotein and total cholesterol. LDX was well tolerated and was not associated with any serious adverse events, but there was one case of suspected misuse. The small sample size (because of premature study termination by the funding sponsor) may have limited the detection of important drug-placebo differences. Larger studies on the use of psychostimulants for treatment of bipolar depression seem warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/yic.0000000000000051

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 3

  1. 2000, Bipolar Disord, 2, 56, 10.1034/j.1399-5618.2000.020108.x · DOI · Paper page
  2. 1991, Sleep, 14, 540, 10.1093/sleep/14.6.540 · DOI · Paper page
  3. 1978, Am J Psychiatry, 135, 1420, 10.1176/ajp.135.11.1420 · DOI

Cited by

See all 43

Metadata

Authors
McElroy, S. L., Martens, B. E., Mori, N., Blom, T. J., Casuto, L. S., Hawkins, J. M., & Keck, P. E.
Venue
International Clinical Psychopharmacology
Published
2015-01
Volume
30
Issue
1
Pages
6-13
ISSN
0268-1315 (ISSN-L)
OpenAlex
W1963721789
Cited by
43
References
0
FWCI
3.14
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial. https://app.cochat.ai/papers/10.1097/yic.0000000000000051
The paper
McElroy, S. L., Martens, B. E., Mori, N., Blom, T. J., Casuto, L. S., Hawkins, J. M., & Keck, P. E. (2015). Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000051

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.